Introduction
============

Biological research supports a key role for oxidative stress in atherogenesis; free radical-mediated damage induces oxidative changes in low-density cholesterol particles that initiate and promote atherosclerotic changes. This process could be reversed or prevented by the use of antioxidants^[@r01]^. Observational studies have shown inverse associations between antioxidant intake and cardiovascular events^[@r02]^, but randomized clinical trials have not shown any benefit of antioxidants in cardiovascular events^[@r03]^. However, these studies did not focus on patients with diabetes mellitus (DM), a population with high cardiovascular disease risk.

Coronary and cerebrovascular diseases, which are caused primarily by atherosclerosis, are the major cause of morbidity and mortality in patients with DM^[@r04]^, and occur more frequently and more severely in these patients^[@r05]^. Hyperglycemia in DM is characterized by a high oxidative stress state^[@r06]^, which is closely related to the genesis of chronic complications of diabetes, including cardiovascular diseases^[@r07]^. Particular attention has been given to the applicability of antioxidant therapy (endogenous enzymes and dietary substances) in the prevention and management of diabetic complications, especially atherosclerotic cardiovascular disease^[@r08]^.

Lifestyle changes and a healthy diet are included in the prevention and/or treatment of atherosclerosis in patients with or without DM. High intake of fruits, vegetables, whole grains, and oil seeds and low intake of sodium are usually recommended^[@r09]^. Epidemiological studies have shown that certain foods with antioxidant properties are associated with a reduction in inflammatory markers and low-density cholesterol oxidation^[@r08]^, and consequently, improved endothelial function^[@r10]^.

The aim of this study was to systematically review the role of vitamins (vitamins A, C, and E) and minerals (zinc, selenium, chromium, manganese, and copper) with antioxidants properties in the presence or development of clinical cardiovascular outcomes in patients with DM.

Methods
=======

Literature search
-----------------

The search was performed to select observational studies that evaluated the role of antioxidant micronutrient intake (vitamins and minerals) in the presence or development of cardiovascular events in patients with DM. The databases used in the search were *Medline* from*Pubmed, Embase*, and *Scopus* for the period from January 1949 to March 2012. The search strategy included terms referring to antioxidant micronutrients: \"*micronutrients,\" \"antioxidant micronutrient,\" \"trace elements,\" \"biometals,\" \"antioxidants,\" \"vitamins,\" \"antioxidant vitamins,\" \"vitamin C,\" \'ascorbic acid,\" \'vitamin E,\" \"tocopherols,\" \"alfa-tocopherol,\" \"*β*-carotene,\" \"vitamin A,\" \"pro-vitamin A,\" \"minerals,\" \"antioxidant minerals,\" \"diet,\" \"diet therapy,\" \"zinc,\" \"copper,\" \"manganese,\" \"chromium,\" \"selenium\"*, to patients (type 1 or type 2 DM): \"*Diabetes Mellitus, Type 1,\" \"Diabetes Mellitus, Insulin-Dependent,\" \"Diabetes Mellitus, Juvenile-Onset,\" \"Diabetes Mellitus, Sudden-Onset,\" \"Diabetes Mellitus, Type I,\" \"IDDM,\" \"Diabetes Mellitus, Brittle,\" \"Diabetes Mellitus, Ketosis-Prone,\" Autoimmune Diabetes, \"Diabetes Mellitus, Type 2,\" \"Diabetes Mellitus, Ketosis-Resistant,\" \"Diabetes Mellitus, Non-Insulin-Dependent,\" \"Diabetes Mellitus, Slow-Onset,\" Stable Diabetes Mellitus, \"Diabetes Mellitus, Type II,\" NIDDM, \"Diabetes Mellitus, Adult-Onset,\" \"Diabetes Mellitus, Noninsulin Dependent,\" \"Maturity-Onset Diabetes Mellitus,\"* and type of study (observational), using a previously validated list of terms available at: <http://www.sign.ac.uk/methodology/filters.html#obs>.

The search strategy described above was used to identify studies on *Pubmed*. Similar terms were searched for in other databases. There was no restriction of the language used in the publications. The article references included in this review were consulted to identify other potentially eligible studies.

Inclusion and exclusion criteria
--------------------------------

We included observational studies (case-control studies and cohorts irrespective of their prospective or retrospective nature) that evaluated the role of antioxidant micronutrient intake (from diet and/or supplements) in the presence or development of major cardiovascular events such as myocardial infarction or revascularization, stroke, sudden death, and death from cardiovascular causes in patients with type 1 or type 2 DM.

In selecting the studies, the antioxidant micronutrients looked at were vitamin A (beta-carotene), vitamin C (ascorbic acid), vitamin E (tocopherol), zinc, selenium, chromium, manganese, and copper. The outcomes considered were major cardiovascular events (cardiovascular death, stroke, myocardial infarction, and myocardial revascularization) and their individual components (fatal and non-fatal myocardial infarction, fatal and non-fatal stroke, sudden death or myocardial revascularization).

Study selection and data extraction
-----------------------------------

Two reviewers (R.A.S. and F.M.S.) independently reviewed the titles and abstracts of each article identified in the literature search. In this first stage all articles that clearly did not meet the inclusion criteria were rejected. The selected articles were analyzed by reading the full text, and the eligible articles were then identified. Disagreements between reviewers at this stage of article analysis were resolved by discussion. The concordance, estimated by Kappa coefficient, was good (Kappa = 0.79).

Data extraction from each study included in this review was conducted independently by two reviewers (R.A.S. and F.M.S.) using a standardized instrument. The data extracted were publication identification, study design, sample size, follow-up duration (in cohort studies), and participants\' general characteristics (type of DM, age, gender, body mass index, diabetes treatment, hypertension, and smoking). The data on diet characteristics and micronutrient antioxidants evaluated (quantity, measurement unit, and assessment method) were also extracted. The data extracted concerning cardiovascular outcomes were event type, case numbers, and the estimated risk as presented in the manuscript \[relative risk (RR), odds ratio (OR), or hazard ratio (HR)\]. We extracted the risk estimate data that considered the largest number of covariates in the analyses.

Quality assessment of studies
-----------------------------

The methodological quality of each study included in this review was assessed independently by two reviewers (R.A.S. and F.M.S.) from a questionnaire developed by the authors. The questionnaire was based on four instruments for quality assessment of observational studies designed by the Scottish Intercollegiate Guidelines Network and Critical Appraisal Skills Programme, as proposed in the Cochrane Handbook^[@r11]^. The questionnaire included issues related to the study aim (clarity and specificity), the inclusion and exclusion criteria used to select the participants, sample size of groups, number of patients lost from each group, assessment form of exposure status to the factor studied, and outcomes (if standardized assessment was made by blinded investigators as to the participant exposure status).

Results
=======

Literature search
-----------------

From the 15 658 articles identified, 2865 were excluded because they were duplicated among the databases searched. After analysis of titles and abstracts, 12 766 articles were excluded because they did not meet the inclusion criteria and 27 articles were selected for reading the full text. After evaluating the full texts, 22 articles were excluded because of the following criteria: five studies were not observational, one study involved patients with pre-diabetes and without diabetes, three studies did not assess antioxidant micronutrient effect, seven studies did not evaluate cardiovascular outcomes, and six studies included DM as a covariate in estimating cardiovascular risk and sub-analyses did not include only patients with DM. New articles were not identified from the reference lists of studies consulted. Therefore, five studies were included in this review^[@r12]-[@r16]^. The study selection flow diagram is shown in [Figure 1](#f01){ref-type="fig"}.

![The study selection flow diagram.](abc-101-03-0240-g01){#f01}

General characteristics of the studies
--------------------------------------

The main characteristics of the five studies included are described in [Table 1](#t01){ref-type="table"}. Three of them presented a case-control design^[@r12],[@r14],[@r15]^ and two were cohort studies^[@r13],[@r16]^ with a follow-up ranging from 7^[@r16]^ to 15 years^[@r13]^. One study was conducted in patients with type 1 DM^[@r15]^, one study included patients with type 2 DM^[@r16]^, and in one manuscript the authors reported that the majority of the participants had type 2 DM^[@r13]^. The other two studies did not specify the type of diabetes^[@r12],[@r14]^. Sample size ranged from 121^[@r15]^ to 1923 participants^[@r13]^. The age of the patients ranged from 34 to 75 years. Two studies included both men and women^[@r15],[@r16]^, two studies were performed only in men^[@r12],[@r14]^, and one study was conducted only in women^[@r13]^. Two studies described the treatment of DM; in one of them most of the participants were using oral antidiabetic agents^[@r16]^; whereas in the other study, approximately 70% of patients were using insulin and/or oral antidiabetic agents^[@r13]^. Only two studies reported the number of hypertensive participants, current smokers, and the waist-to-hip ratio values^[@r13],[@r15]^.

###### 

Main features of studies

  **Author, year**                 **Design (follow-up)**   **n**   **DM**         **DM duration**   **Age (years)**   **Gender**    **BMI (kg/m^2^)**   **Micronutrient**
  -------------------------------- ------------------------ ------- -------------- ----------------- ----------------- ------------- ------------------- -------------------
  Rajpathak et al^[@r12]^(2004)    case-control             886     not reported   not reported      40-75             100% men      not reported        chromium
  Lee et al^[@r13]^ (2004)         cohort (15 years)        1923    not reported   10.3 years        62.2              100% women    30.1                vitamin C
  Rajpathak et al^[@r14]^ (2005)   case-control             886     not reported   not reported      40-75             100% men      not reported        selenium
  Costacou et al^[@r15]^ (2006)    case-control             i2i     type 1         26.7 years        34.6              47.9% women   24.2                a-tocopherol
  Soinio et al^[@r16]^ (2007)      cohort (7 years)         i059    type 2         not reported      45-64             45.1% women   27.9                zinc

DM: Diabetes Mellitus; BMI: body mass index.

Different antioxidant micronutrients were evaluated in the studies and different methods were used to measure them. Vitamin C provided in dietary intake and/or supplementation was assessed by food frequency questionnaire^[@r13]^, chromium and selenium were quantified in samples^[@r12],[@r14]^, and α-tocopherol and zinc were measured in serum^[@r15],[@r16]^. The usual diet composition was not described in any study, only a partial dietary description of saturated fatty acids, vitamin E, and beta-carotene was reported in one study^[@r13]^.

Cardiovascular outcomes were differently evaluated among the studies: two studies evaluated the presence of cardiovascular disease^[@r12],[@r14]^, two reported the presence of coronary artery disease^[@r15],[@r16]^ and one other study reported mortality by cardiovascular disease, coronary heart disease, and stroke^[@r13]^. Because of these differences we could not perform a meta-analysis of the data extracted. Therefore, the main results of each study included in this review are shown in [Table 2](#t02){ref-type="table"} and discussed.

###### 

Main results of the studies Included In the review

  **Author (year)**                       **Micronutrient (measure unit)**             **Statistical analysis criteria**             **Outcome (number of cases /total number)**   **RR/OR/HR (CI 95%)**                                                                                                                                                                              **Variables considered for adjustment in multivariate analysis**                                                                                                                                    
  --------------------------------------- -------------------------------------------- --------------------------------------------- --------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Rajpathak et al. (2004)^[@r12]^         toenail chrome (μg/g)                        upper quartile (\>2.08) vs. other quartiles   CVD (198/886)                                 OR = 0.68 (0.42-1.10)                                                                                                                                                                              Age, BMI, alcohol, smoking, family history of AMI, physical activity, hypercholesterolemia, hypertension, dietary fats, fiber, glycemic load, folate and selenium levels, and mercury in toenail.   
  Lee et al. (2004)^[@r13]^               vitamin C (mg/day)                           diet and supplementation                      upper quintile (\>667) vs. other quintiles    CVD (281/1923)                                                                                                                                                                                     RR = 1.84 (1.12-3.01)                                                                                                                                                                               Age, energy, WHR, BMI, physical activity, smoking, alcoholism, education, marital status, HRT, treatment and duration of DM, dietary fats, vitamin E, β-carotene and folate.
  CAD (175/1923)                          RR = 1.91 (1.05-3.48)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Stroke (57/1923)                        RR = 2.57 (0.86-7.66)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  only diet                               upper quintile (\>251) vs. other quintiles   CVD (281/1923)                                RR = 1.11 (0.66-1.87)                         Age, energy, WHR, BMI, physical activity, smoking, alcoholism, education, marital status, HRT, treatment and DM duration, dietary fats, vitamin E, p-carotene, folate,and vitamin C supplements.                                                                                                                                                                                                       
  CAD (175/1923)                          RR = 1.08 (0.57-2.06)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Stroke (57/1923)                        RR = 1.89 (0.60-6.03)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  only supplementation                    upper quartile (\>300) vs. other quartiles   CVD (281/1923)                                RR = 1.69 (1.09-2.44)                         Age, energy, WHR, BMI, physical activity, smoking, alcoholism, education, marital status, HRT treatment and DM duration, and vitamin C.                                                                                                                                                                                                                                                                
  CAD (175/1923)                          RR = 2.07 (1.27-3.38)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Stroke (57/1923)                        RR = 2.37 (1.01-5.57)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Rajpathak et al. (2005)^[@r14]^         toenail selenium (μg/g)                      upper quartile (\>1.20) vs. other quartiles   CVD (198/886)                                 OR = 1.47 (0.92-2.35)                                                                                                                                                                              Age, BMI, alcohol, smoking, family history of MI, physical activity, hypercholesterolemia, hypertension, dietary fats, fiber, glycemic load, folate and chromium, and mercury levels in toenail.    
  Costacou et al. (2006)^[@r15]^          serum α-tocopherol (μg/ml)                   high levels (\>10.45) vs. low levels          CAD (54/121)                                  HR = 0.71 (0.53-0.94)                                                                                                                                                                              Adjustment model is not specified.                                                                                                                                                                  
  Soinio et al. (2007)^[@r16]^            serum zinc (μmol/L)                          lower quartile (\<14.1) vs. other quartiles   Fatal CAD (156/1059)                          RR = 1.70 (1.21-2.38)                                                                                                                                                                              Age, sex, DM duration, total cholesterol, HDL-c, triglycerides, HbAlc, GFR, hypertension, smoking, BMI, residence place, and DM treatment.                                                          
  Fatal CAD or non-fatal AMI (254/1059)   RR = 1.37 (1.03-1.82)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           

CAD: coronary artery disease; CVD: cardiovascular disease; DM: Diabetes Mellitus; AMI: acute myocardial infarction; OR: odds ratio; HR: hazard ratio; RR: relative risk; CI: confidence interval; WHR: waist-to-hip ratio; BMI: body mass index; HRT hormone replacement therapy; HDL-c: HDL-cholesterol; HbA1c: glycated hemoglobin; GFR: glomerular filtration rate.

Main findings of the studies
----------------------------

### Antioxidant vitamins and cardiovascular outcomes

The role of antioxidant vitamins in cardiovascular disease development was evaluated in two studies^[@r13],[@r15]^.

The relationship between vitamin C intake (assessed by a food frequency questionnaire validated in a subsample of the study population) and cardiovascular outcomes in postmenopausal women with DM was evaluated in a prospective cohort study followed for 15 years^[@r13]^. Cardiovascular outcomes (cardiovascular disease mortality, coronary heart disease and stroke) were defined based on the International Classification of Diseases: the codes potentially related to the diagnoses of interest were selected according to the description in the records of local deaths (Iowa, USA). Vitamin C intake of more than 667 mg/day (diet and/or by supplementation) approximately doubled the risk of mortality from cardiovascular disease and coronary artery disease in patients with diabetes. When dietary and supplemental vitamin C were analyzed separately, only supplemental vitamin C showed a positive association with mortality endpoints: the use of at least 300 mg/day of vitamin C supplements was associated with higher risk of cardiovascular disease mortality (RR 1.69; 95%CI 1.09-2.44), coronary artery disease (RR 2.07; 95%CI 1.27-3.38) and stroke (RR 2.3; 95%CI 1.01-5.57) than using smaller quantities of supplementation.

The effect of α-tocopherol, γ-tocopherol, and retinol on the incidence of coronary artery disease in patients with type 1 DM was evaluated in a study of 54 cases and 67 controls derived from a cohort study conducted in Pittsburgh, USA^[@r15]^. Cases were defined by the participants who first developed coronary artery disease, as determined by one of the following criteria: physician-diagnosed angina, myocardial infarction confirmed by Q-waves on electrocardiogram, hospital records (Minnesota code 1.1 or 1.2), angiographic stenosis ≥50%, coronary artery bypass surgery, angioplasty, or ischemic electrocardiographic changes during the follow-up period. Serum levels of α-tocopherol ≥10.45 µg/ml were inversely associated with coronary artery disease (HR 0.71; 95%CI 0.53-0.94). However, when multivitamin supplement users were compared to nonusers, the protective effect of this micronutrient was observed only among supplement users (HR 0.22; 95%CI 0.10-0.49). It is noteworthy that the authors did not specifically report the type of supplement used by the study participants.

### Antioxidant minerals and cardiovascular risk

The possible association between zinc, chromium and selenium and presence or development of cardiovascular events in patients with DM were evaluated by three studies^[@r12],[@r14],[@r16]^.

A cohort study with 7 years of follow-up investigated serum zinc levels as a predictor of coronary artery disease in 1050 patients with type 2 DM from Finland^[@r16]^. The outcomes evaluated were mortality from coronary artery disease based on medical records and death certificates, and myocardial infarction incidence according to the World Health Organization criteria (chest pain, enzyme changes and electrocardiogram). Patients with ≤ 14.1 µmol/L of serum zinc at baseline were at higher risk of death from coronary artery disease (RR 1.7; 95%CI 1.21-2.38) and fatal and non-fatal myocardial infarction (RR 1.37; 95%CI 1.03-1.82) than patients with serum levels ≥14.1 µmol/L.

In a case-control study (derived from the *Health Professionals Follow-up Study*), toenail levels of chromium^[@r12]^ or selenium^[@r14]^ were determined in 198 male patients with DM and prior cardiovascular disease, as well as 688 male patients with DM and without cardiovascular disease. Cardiovascular disease was considered present when subjects presented fatal or non-fatal myocardial infarction as defined by the World Health Organization criteria, coronary artery bypass grafting, angioplasty or stroke. In a multivariate analysis adjusted for the other potential confounding factors, there was no association between chromium^[@r12]^ or selenium^[@r14]^ levels and cardiovascular outcomes.

### Quality evaluation

Quality evaluation is shown in [Table 3](#t03){ref-type="table"}. None of the studies included meets all the criteria previously established to evaluate methodological quality. However, all five studies were for the purpose of answering a clear and focused question and four of them assessed the exposure status and outcomes in a standardized and valid method. The information regarding the outcomes was collected from population-based registries in the two cohort studies selected^[@r13],[@r16]^. In the three case-control studies^[@r12],[@r14],[@r15]^, outcomes were measured in a valid and standardized way. Potential confounding factors were considered in analysis of data from four studies^[@r12]-[@r14],[@r16]^. Only one study showed no clear results, because the authors did not describe which covariates were used for multivariate regression adjustment^[@r15]^. Among the three case-control studies, none of them described whether the follow-up losses were similar between the groups^[@r12],[@r14],[@r15]^. In the two cohort studies^[@r13],[@r16]^, follow up duration was considered appropriate and the selection of participants was controlled for potential confounding factors.

###### 

Methodological quality of studies included in this review

                                                                     **Cohort studies**                    **Case-control studies**                    
  ------------------------------------------------------------------ -------------------- ---------------- -------------------------- ---------------- ----------------
  Issue clear, focused, and appropriate                              Yes                  Yes              Yes                        Yes              Yes
  Exposure status assessed by valid and standardized way             Yes                  Yes              Yes                        Yes              No
  Outcomes assessed by valid and standardized way                    Yes                  Yes              Yes                        Yes              Yes
  Outcomes evaluated by investigators blinded to the exposure        Not described        Not described    Yes                        Yes              Not described
  Potential confounding factors considered in the analysis of data   Yes                  Yes              Yes                        Yes              Not described
  Results clearly presented and discussed                            Yes                  Yes              Yes                        Yes              No
  **Items related to cohort studies**                                                                                                                  
  Sufficient follow-up duration                                      Yes                  Yes              Not applicable             Not applicable   Not applicable
  Selection of participants controlled for potential confounders     Yes                  Yes              Not applicable             Not applicable   Not applicable
  **Items related to case-control studies**                                                                                                            
  Sample size similar between cases and controls                     Not applicable       Not applicable   No                         No               Yes
  Data collected similarly for cases and controls                    Not applicable       Not applicable   Yes                        Yes              Yes
  Exclusion criteria applied similarly for cases and controls        Not applicable       Not applicable   Not described              Not described    Not described
  Clearly defined cases                                              Not applicable       Not applicable   Yes                        Yes              Yes
  Controls clearly defined                                           Not applicable       Not applicable   Yes                        Yes              Yes
  Follow-up losses similar between cases and controls                Not applicable       Not applicable   Not described              Not described    Not described

Discussion
==========

The purpose of this systematic review was to evaluate the role of antioxidant micronutrients in the presence or development of cardiovascular events in patients with DM. However, the high clinical heterogeneity among the studies obtained hindered the performance of a meta-analysis. Moreover, information on this issue is scarce and of low quality. Vitamin C, vitamin E (α-tocopherol), zinc, selenium, and chromium were micronutrients with antioxidant properties evaluated by the case-control and cohort studies included in this review. The outcomes analyzed were myocardial infarction, stroke, myocardial revascularization, sudden death, and death from cardiovascular causes.

The use of more than 300 mg/day of vitamin C by supplementation was associated with increased cardiovascular risk^[@r13]^. Interestingly, this is not what is reported for subjects without diabetes^[@r02],[@r17]^. A systematic review of 15 cohort studies with 374,488 subjects without DM showed an inverse association between higher intake of vitamin C (diet and supplement) and risk of coronary artery disease (RR 0.84; 95%CI 0.73-0.95)^[@r02]^, but the results were not confirmed with the use of supplemental vitamin C only in the same study^[@r02]^. In clinical trials with long follow-up periods analyzed in other reviews, vitamin C supplement use had no significant effect on the risk of myocardial infarction and stroke in subjects without diabetes^[@r17]^. The inconsistency of these findings may be partially explained by the presence of diabetes and the recommended daily intake of the vitamin. Vitamin C can act as a pro-oxidant interacting with free iron^[@r18]^ and among patients with DM an iron metabolism disorder seems to occur, with an increase in free iron stores^[@r19]^. Alternatively, vitamin C could have promoted protein glycation^[@r20]^ and stimulated lipid peroxidation^[@r21]^, with a possibly deleterious effect on the cardiovascular system as higher doses were administered. The daily vitamin C supplementation amount used was higher than the recommended daily intake for adults (90 mg/day for men and 75 mg/day for women), but lower than the maximum tolerable level (2000 mg/day)^[@r22]^.

Reduced serum levels of α-tocopherol were inversely associated with the incidence of coronary artery disease^[@r15]^, according to prospective observational studies in individuals without DM and/or without previous cardiovascular disease^[@r23],[@r24]^. The α-tocopherol form of vitamin E is the most biologically active and could be considered a good biomarker of the consumption of this vitamin^[@r25]^. However, the beneficial effect observed in the study included in the current review occurred among users of antioxidant supplements, without specifying the supplement type and quantity^[@r15]^. Moreover, increased mortality from all causes^[@r03]^ in subjects without DM was demonstrated with 10-5000 IU/day of vitamin E supplementation in randomized clinical trials. A possible explanation of the adverse effects described is that vitamin E can inhibit platelet function^[@r26]^.

High serum zinc was shown to be protective against the development of cardiovascular disease^[@r16]^, a result that is in accordance with other studies in patients without DM^[@r27],[@r28]^. Patients with type 2 DM presented lower values of serum zinc (9.23 µmol/L *vs.* 12.46 µmol/L, p \< 0.001) compared with patients without DM, suggesting a lower antioxidant capacity in diabetes^[@r29]^. Possibly, the importance of maintaining high serum zinc values is due to their role in an endogenous antioxidant system^[@r30]^ and/or because zinc plays a clear role in the synthesis, storage and secretion of insulin^[@r31]^.

Chromium^[@r12]^ and selenium^[@r14]^, which were measured in the toenail, were not associated with cardiovascular outcomes in patients with DM in the studies included in this review. This result is different from what was observed in subjects without DM in a case-control study performed in eight European countries and Israel (EURAMIC study)^[@r32]^. In the EURAMIC study, chromium levels in nails was inversely associated with the occurrence of myocardial infarction (OR 0.59; 95%CI 0.37-0.95)^[@r32]^. Moreover, chromium^[@r33]^ and zinc^[@r31]^ are beneficial in regulating insulin action and energy metabolism. Better glycemic control could be reflected in lower cardiovascular outcomes^[@r34]^. In a recent systematic review with meta-analysis, chromium supplementation (1.28 to 1000 mcg/day) decreased the glycated hemoglobin values in 381 patients with DM by 0.6% (95%CI -0.9 to -0.2)^[@r35]^. However, cardiovascular outcomes were not evaluated in that study.

The study which evaluated selenium included in the current review was not in accordance with a recent meta-analysis of 25 observational studies^[@r36]^ that demonstrated a reduction of 24% (95%CI 7-38) in the risk of coronary artery disease with an increase of 50% in selenium levels (assessed by different methods). Selenium is another essential mineral involved in antioxidant defense, since it is part of *glutathione peroxidase*, a selenoprotein. In this context, low serum selenium has been linked to increased risk of cardiovascular disease in subjects without DM^[@r37]^. The effects of selenium supplementation (200 µg/day) in the prevention of cardiovascular events were not confirmed in a randomized clinical trial^[@r36]^ or in a prospective study having a follow-up of 7.6 years^[@r38]^, probably due to its narrow therapeutic range. Selenium deficiency in humans appears to be just one factor in a complex set of nutritional variables that may predispose or protect against cardiovascular disease^[@r37]^. One of the limitations common to studies with selenium and chromium included in this review involves the measurement method adopted. Although the levels of these minerals in the toenail may reflect the long-term intake of the mineral^[@r25]^, samples contamination could be a source of error^[@r12],[@r14]^.

Our systematic review has several limitations: 1. the low quality of the original studies; 2. no study included meets all items previously established to evaluate methodological quality and potential confounding factors were considered in the analysis of data just from four studies^[@r12]-[@r14],[@r16]^; 3. no sensibility analysis was carried out due to clinical heterogeneity of studies included; 4. the case-control studies did not allow us to establish a cause-consequence between micronutrients intake and cardiovascular outcomes. Also, the results for supplementation of vitamin C derived from a single cohort study and need to be considered with caution.In conclusion and according to available evidence, information about antioxidant micronutrient intake and cardiovascular risk in individuals with DM is too scarce to determine which micronutrient antioxidants might be related to cardiovascular outcomes in the DM population. Moreover, the antioxidant property of micronutrients appears to be only one factor in a complex set of nutritional variables that may predispose or protect against cardiovascular disease. Further studies should be performed to explore the relationship between antioxidant micronutrient intake and the development of cardiovascular disease in patients with DM, preferably randomized controlled trials. The description of the results of this review will aid researchers interested in investigating the topic to develop their hypotheses.
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